Coordination aspects of pharmacovigilance system adjustment in terms of the global COVID-19 pandemic

Abstract

The purpose is to overview the crucial pharmacovigilance system adjustment measures concerning COVID-19 widespread pandemic and enlightens main current aspects of pharmacovigilance system revamp. Materials and methods. There were used common science theoretical methods (system analysis, generalization and systems approach); bibliographic method (elaboration of scientific related literature on topic). Results. Revamping pharmacovigilance system requires being improved in regulatory capacities, the use of appropriate public-health-driven science-based and user-friendly technologies, including digital technologies, and innovations to expand access to quality medical and relevant information. These proposals can promote health by putting pharmacovigilance at the center of efforts to achieve a sustainable healthcare system that uses universal health coverage and the health-related Sustainable Development Goals. Conclusion. Vaccine safety is very important for the success of any vaccination program. A robust vigilance system will help detect, report and prevent any adverse reactions associated with vaccination. Effective pharmacovigilance of the COVID-19 vaccine, when ready for use, will prevent any adverse events associated with the vaccine and dispel any unreasonable concerns among vaccine users.

Keywords

• pharmacovigilance, COVID-19, vaccination, side effects.